Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Immunome is seeking a Senior Director, Brand Lead - Varegacestat to lead the US launch efforts for Varegacestat, a potential best-in-class agent for desmoid tumors. The ideal candidate will have advanced expertise in pharmacology and clinical therapeutics to drive HCP education, shape the brand’s scientific narrative, and ensure effective communication of Varegacestat’s clinical value.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Immunome, Inc.